Pharmacokinetics (PK) and toxicokinetics (TK) are not simply checkbox requirements—they are often the hinge on which a program’s success turns. Dose selection, safety margins, and translational relevance all rest on how well the exposure data is understood and applied. Resero Analytics now formally launches its full-service PK/TK offering—built around deep scientific expertise, a purpose-built analysis platform, and a commitment to fast, accurate, and decision-ready data delivery.

Whether supporting early discovery or clinical trials, Resero’s PK/TK services interpret customers’ concentration-time datasets and create study reports and PPT slide sets with unparalleled speed and accuracy.

Precision Services Anchored by TurboPKTK

At the core of Resero’s offering is TurboPKTK, our proprietary software engine that enables rapid, GLP-compliant noncompartmental analysis (NCA) followed by automated report creation. But what underlies this service offering is our unique blend of scientific software and drug development expertise — to deliver speed and interpretive rigor not found in other outsourced solutions.

Here’s how it works:

1. Data Load: We accept concentration data in multiple formats—Excel, CSV, or direct LIMS APIs. Our flexible pipeline supports automated or manual data loads.
2. Automated Quality Review: TurboPKTK instantly flags outliers, data inconsistencies, and integrity issues—allowing immediate triage and time savings. This process is transparent to clients, including as an appendix in reports or as standalone QC reports.
3. SOP-Driven Analysis: Our software applies a validated, GLP- and Part 11-compliant framework for identifying outliers, calculating PK parameters, and evaluating exposure proportionality. Every step is auditable and reproducible.
4. Full Reporting Suite: We generate high-resolution graphs, formatted tables, study narratives, and SEND-ready datasets. These outputs are available rapidly—often the same day as the final data load—shortening timelines from weeks to hours.

Expertise Beyond the Algorithm

Unlike software-only platforms and alternatives service providers, Resero provides interpretive depth rooted in decades of real-world drug development experience. Our team has collectively contributed to hundreds of programs across discovery, preclinical, and clinical drug development. We understand that context matters as much as computational power.

Whether you’re:

• Estimating a first-in-human starting dose based on animal TK data,
• Interpreting exposure-response relationships for IND-enabling toxicology,
• Or evaluating ADME properties across compounds to prioritize a lead,

…our experts engage not just as analysts, but as thought partners—helping clients understand not just what the numbers say, but what they mean for development decisions.

Tailored for Small and Midsize Biotechs

In large pharma, pharmacokinetic modeling groups are often embedded in-house. In smaller organizations, however, the reality is different. The person managing PK/TK may be a scientist wearing multiple hats and is rarely a full-time pharmacokineticist.

That’s where Resero’s integrated service model delivers the greatest value.

• We handle the analysis from end to end—from loading and quality reviewing raw data to generating full reports.
• Clients do not need to be software users themselves—our team manages use of the TurboPKTK platform on behalf of clients all the way to final report.
• We support both non-GLP and GLP datasets—and can scale across programs to provide cross-study harmonization and development continuity.

In short, we provide not just “analysis as a service,” but end-to-end service.

What Sets Resero Apart

Many organizations offer pharmacokinetic consulting. Resero offers something more: a seamless fusion of software-driven efficiency and human expertise.

Our services are:

• Fast — Reports delivered in hours, not weeks
• Flexible — Compatible with your existing systems and data formats
• Validated — Built on GLP- and Part 11-compliant workflows
• Scalable — From one study to full program support
• Integrated — Software and science working together, not in silos

And above all: we speak the language of scientists. Our audience isn’t learning PK/TK—they’re applying it. We meet them where they are, and help them move forward faster, with confidence.

Services Launched in 2025

While our TurboPKTK software has evolved over years of development and deployment, our service offering formally launched in 2025. Early client engagements are already underway, and we’re scaling quickly to meet demand across discovery, nonclinical, and clinical development programs.

If your team is navigating complex exposure data and needs rapid, reliable PK/TK insights—Resero Analytics is ready.

Contact us today to discuss your project or request a service proposal.